The analysis using the TCGA dataset showed that TNFRSF9 was altered in approximately 5% of cases of Cholangiocarcinoma, adrenocortical carcinoma (ACC) and lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), with deep deletion being the dominant alteration (Supplementary Figure S8A). This evidence concerns the gene TNFRSF9 and diffuse large B-cell lymphoma.